secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2023-10-30T23:59:59+00:00
Accession:  0001493152-23-038668
Event type: debt
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma closes $40K convertible note with investor
------------------------------------------------------------

- Closed sale of $40K convertible promissory note to an investor on Oct 29, 2023.
- Note is convertible into common shares at investor's option after 180 days from issuance.
- Funds were received and transaction closed on Oct 29; initially disclosed on Oct 26, 2023.
- Proceeds likely for general working capital; no other material terms changed from prior disclosure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315223038668/0001493152-23-038668-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315223038668/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-038668

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer